GenCefe Biotech is pleased to announce its participation in BioJapan 2025, taking place from October 8 to 10 at PACIFICO Yokohama, Japan.

In order to further standardize our product specifications and improve the ordering process, GenCefe Biotech will implement the following adjustments to our siRNA products

GenCefe Biotech announced the official launch of its newly redesigned corporate website. The upgraded platform delivers a modern look, improved navigation, and enhanced functionality to better serve researchers worldwide.

GenCefe Biotech is proud to announce that it has successfully obtained ISO 13485 certification, a globally recognized standard for quality management systems in the medical device and biotechnology industries.

GenCefe Biotech Co., Ltd., a leading provider of Oligonucleotide, Gene, and Protein Synthesis Services, is pleased to announce the signing of an exclusive distributor agreement with Medsol Corporation.

GenCefe Biotech Co., Ltd., a leading provider of Oligonucleotide, Gene, and Protein Synthesis Services, is pleased to announce the signing of an exclusive distributor agreement with Bionics , a prominent supplier in equipment, biochemicals, and molecular biology products. This strategic partnership aims to expand GenCefe's presence and strengthen its market position in Pakistan .

At the invitation of GenCefe, the Academician of Chinese Academy of Engineering, and Former President of Jiangnan University, Dr. Jian Chen, visits GenCefe on February 27th.